Clinical Trial Update: Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the combination of irreversible electroporation and NK cell immunotherapy in advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Irreversible Electroporation
• NK immunotherapy (natural killer cell-based immunotherapy)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED